Selective Inhibition of Trigeminovascular Neurons by Fremanezumab: A Humanized Monoclonal Anti-CGRP Antibody. - Melo-Carrillo, A; Noseda, R; Nir, R (J Neurosci Off J Soc Neurosci, 2017)